Ulys
Latest statistics and disclosures from Ulys's latest quarterly 13F-HR filing:
- Top 5 stock holdings are LXRX, and represent 100.00% of Ulys's stock portfolio.
- Ulys has $25M in assets under management (AUM), dropping by 71.64%.
- Central Index Key (CIK): 0001340098
Tip: Access up to 7 years of quarterly data
Positions held by Ulys consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Ulys
Ulys holds 1 positions in its portfolio as reported in the March 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Lexicon Pharmaceuticals Com New (LXRX) | 100.0 | $25M | 4.3M | 5.87 |
|
Past Filings by Ulys
SEC 13F filings are viewable for Ulys going back to 2011
- Ulys 2021 Q1 filed May 14, 2021
- Ulys 2020 Q4 filed Feb. 11, 2021
- Ulys 2020 Q3 filed Nov. 13, 2020
- Ulys 2020 Q2 filed Aug. 14, 2020
- Ulys 2020 Q1 filed May 14, 2020
- Ulys 2019 Q4 filed Feb. 13, 2020
- Ulys 2019 Q3 filed Nov. 14, 2019
- Ulys 2019 Q2 filed Aug. 9, 2019
- Ulys 2019 Q1 filed May 13, 2019
- Ulys 2018 Q4 filed Feb. 11, 2019
- Ulys 2018 Q3 filed Nov. 9, 2018
- Ulys 2018 Q2 filed Aug. 10, 2018
- Ulys 2018 Q1 filed May 10, 2018
- Ulys 2017 Q4 filed Feb. 9, 2018
- Ulys 2017 Q3 filed Nov. 8, 2017
- Ulys 2017 Q2 filed Aug. 11, 2017